MARK A. GOLDSMITH - 09 Aug 2022 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
09 Aug 2022
Net transactions value
+$5,065
Form type
4
Filing time
10 Aug 2022, 17:01:23 UTC
Previous filing
21 Mar 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $5,065 +10,336 +5.5% $0.4900* 196,872 09 Aug 2022 Direct F4, F5
holding RVMD Common Stock 37,032 09 Aug 2022 Trust F1
holding RVMD Common Stock 37,032 09 Aug 2022 Trust F2
holding RVMD Common Stock 266,506 09 Aug 2022 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -10,336 -6.2% $0.000000 157,446 09 Aug 2022 Common Stock 10,336 $0.4900 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F2 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F4 Includes 130,500 RSUs.
F5 Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.

Remarks:

President and Chief Executive Officer